have reported that CLEC5A correlated with immunosuppression in glioma patients (59); meanwhile, CLEC5A was identified as an immune-related prognostic gene of ovarian cancer based on the immune microenvironment (39). The gene discussed is CLEC5A; the disease is glioma.